Auro Laboratories Ltd.

84.65 -2.12 ▼-2.4%

05 June 2023, 04:01:00 PM
Volume: 3,597

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aurolabs.com
Market Cap 52.81 Cr.
Enterprise Value(EV) 56.55 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 3.92 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 21.63 Trailing Twelve Months Ending 2023-03
Industry PE 33.51 Trailing Twelve Months Ending 2023-03
Book Value / Share 54.87 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.54 Calculated using Price: 84.73
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.62 Cr. 6,232,500 Shares
FaceValue 10
About Auro Laboratories Ltd.
Auro Laboratories incorporated in 1989 is engaged in business of manufacturing active pharmaceutical ingredients (API's), intermediates and generic formulations. The company is promoted by Shri Sharat Deorah and Shri Satish Deorah.

Auro Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Auro Laboratories Ltd. Performance

1 Day
-2.44%
1 Week
+0.02%
1 Month
+29.16%
3 Month
+30.23%
6 Month
+11.90%
1 Year
-5.68%
2 Year
-20.18%
5 Year
+6.34%
10 Year
+912.56%

Auro Laboratories Ltd. Fundamental Ratios

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 8.76 11.01 10.83 9.06 31.53 28.95 20.84 28.67 9.47
Return on Capital Employed (%) 9.40 10.76 11.21 20.24 28.65 29.12 24.80 38.88 12.20
Return on Assets (%) 2.04 2.89 3.24 3.11 12.34 13.78 12.32 19.34 5.87

Auro Laboratories Ltd. Balance Sheet

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 7 8 9 9 13 17 22 29 32 34
Non Curr. Liab. 7 8 7 11 8 6 5 4 3 4
Curr. Liab. 13 14 10 6 10 10 6 9 20 18
Minority Int.
Equity & Liab. 27 29 26 27 30 33 32 42 55 56
Non Curr. Assets 11 11 13 13 15 15 14 14 18 20
Curr. Assets 16 18 12 14 16 19 18 28 37 36
Misc. Exp. not W/O
Total Assets 27 29 26 27 30 33 32 42 55 56

Auro Laboratories Ltd. Profit and Loss

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 34 33 28 35 41 47 44 54 51 53
Other Income 0 0 0 1 1 1 1 1 1 1
Total Income 34 33 28 36 41 48 45 55 52 54
Total Expenditure -31 -30 -25 -31 -34 -40 -38 -43 -46 -49
PBIDT 3 3 3 5 7 8 7 12 6 5
Interest -2 -2 -2 -1 -1 -1 -1 0 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation -2 -1 -2 -2 -3 -1 -1
Exceptional Items
PAT 1 1 1 1 4 4 4 7 3 2
Adjusted EPS 1 1 1 1 6 7 7 12 5 4

Auro Laboratories Ltd. Cash Flow

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 4 -1 8 6 5 7 9 13 -7
Cash Fr. Inv. -1 -1 -1 -2 -2 -2 -3 -2 -4 -5
Cash Fr. Finan. -1 -3 1 -5 -4 -2 -2 -6 0 10
Net Change 0 1 -1 0 0 1 2 2 9 -2
Cash & Cash Eqvt 0 1 0 1 1 2 4 6 15 12

Auro Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 51.92 51.92 51.93 51.99 51.99 52.09 52.09 52.09 52.09
Public 48.08 48.08 48.07 48.01 48.01 47.91 47.91 47.91 47.91
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Auro Laboratories Ltd. Announcements

Mon, 29 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
In terms of Regulation 24A of SEBI [Listing Obligations and Disclosure Requirements] Regulation 2015 (Listing Regulations) read with Clause 3(b)(iii) of the above referred SEBI Circular we are submitting the Annual Secretarial Compliance Report of the Company for the year ended March 31 2023 issued by M/s. GMJ & Associates Practicing Company Secretaries enclosed hereunder.
Wed, 17 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
With reference to Regulation 47 of SEBI [Listing Obligations and Disclosure Requirements] Regulation 2015 (Listing Regulations) we are enclosing herewith copies of Newspaper advertisement of Audited Standalone Financial Results of the Company for the quarter and year ended March 31 2023 published in the following Newspapers:1. Mumbai Lakshdeep (i.e. Marathi newspaper) dated May 17 2023.2. Active Times (i.e. English Newspaper) dated May 17 2023
Tue, 16 May 2023
Results - Financial Results Dated 16/05/2023
Pursuant to Regulation 30 & Regulation 33 of SEBI (LODR) Regulations 2015 we wish to inform you that the Board of Directors of the Company at their Meeting held today (i.e. Tuesday May 16 2023) has transacted the following business:1. Approved the Audited Financial Results of the Company for the quarter and year ended March 31 2023 as recommended by the Audit Committee.In this regard we are enclosing herewith: Audited Financial Results for the quarter and year ended March 31 2023 along with the Statement of Assets and Liabilities of the Company and Cash Flow Statement as on that date. Auditors Report on the Financial Results for the quarter & year ended March 31 2023. Declaration regarding Auditor Report with unmodified opinion on the Audited Standalone Financial Results of the Company for the Financial Year ended on March 31 2023.

Auro Laboratories Ltd. Technical Scans

Mon, 05 Jun 2023
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
William %R Trending Down William %R Trending Down

Auro Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 242,260.85 1,009.70 +1.0%
Divi's Laboratories Ltd. 91,882.66 3,461.15 -1.6%
Cipla Ltd. 78,680.17 974.70 +1.0%
Dr. Reddy's Laboratories Ltd. 76,651.29 4,611.30 +0.0%
Apollo Hospitals Enterprise Ltd. 71,154.71 4,948.70 -0.4%
Torrent Pharmaceuticals Ltd. 60,075.76 1,770.00 -0.4%
Mankind Pharma Ltd. 57,049.80 1,424.15 -2.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.59 1,009.70 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 50.39 3,461.15 -1.6%
Cipla Ltd. Consolidated 2023-03 28.08 974.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.04 4,611.30 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.87 4,948.70 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.12 1,770.00 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 42.73 1,424.15 -2.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.33 1,009.70 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7.20 3,461.15 -1.6%
Cipla Ltd. Consolidated 2023-03 3.36 974.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.30 4,611.30 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.50 4,948.70 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.66 1,770.00 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 5.49 1,424.15 -2.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,009.70 +1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,461.15 -1.6%
Cipla Ltd. Consolidated 2022-03 0.04 974.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,611.30 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,948.70 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,770.00 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,424.15 -2.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,009.70 +1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,461.15 -1.6%
Cipla Ltd. Consolidated 2022-03 13.10 974.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,611.30 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,948.70 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,770.00 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,424.15 -2.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,009.70 +1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,461.15 -1.6%
Cipla Ltd. Consolidated 2022-03 13.10 974.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,611.30 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,948.70 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,770.00 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,424.15 -2.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,009.70 +1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,461.15 -1.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 974.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,611.30 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,948.70 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,770.00 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,424.15 -2.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,009.70 +1.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,461.15 -1.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 974.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,611.30 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,948.70 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,770.00 -0.4%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,424.15 -2.9%

Auro Laboratories Ltd. FAQ's

What is Auro Laboratories share price?

Can I buy Auro Laboratories shares now?

What is the Market Cap of Auro Laboratories?

What are the key metrics to analyse Auro Laboratories?

What is the 52 Week High and Low of Auro Laboratories?

What is the trend of Auro Laboratories share price?